TY - JOUR
T1 - Age-Specific Incidence of Alzheimer's Disease in a Community Population
AU - Hebert, Liesi E.
AU - Beckett, Laurel A.
AU - Evans, Denis A.
AU - Scherr, Paul A.
AU - Albert, Marilyn S.
AU - Pilgrim, David M.
AU - Chown, Marilyn J.
AU - Harris Funkenstein, H.
PY - 1995/5
Y1 - 1995/5
N2 - To determine age-specific incidence rates of clinically diagnosed Alzheimer's disease. —Cohort, followed a mean of 4.3 years. —East Boston, Mass. —Of 2313 persons aged 65 years and older who were initially free of Alzheimer's disease, 1601 participated in the ascertainment of incident disease (80% of survivors), 409 declined participation, and 303 died before the end of the follow-up period. A stratified sample of 642 persons received detailed clinical evaluation. —Diagnosis of new probable Alzheimer's disease through structured clinical evaluation including neurologic, neuropsychological, and psychiatric examination. Community incidence rates were computed by 5-year age groups, adjusted for gender, single year of age, length of follow-up interval, and sampling design. —The estimated annual incidence of Alzheimer's disease in the population was 0.6% (95% confidence interval [Cl], 0.3% to 0.9%) for persons aged 65 to 69 years, 1.0% (95% Cl, 0.6% to 1.4%) for persons aged 70 to 74 years, 2.0% (95% Cl, 1.3% to 2.7%) for persons aged 75 to 79 years, 3.3% (95% Cl, 2.2% to 4.4%) for persons aged 80 to 84 years, and 8.4% (95% Cl, 3.7% to 13.1%) for persons aged 85 years and older. —The incidence of Alzheimer's disease is substantial and is approximately 14 times higher among persons older than 85 years compared with those between 65 and 69 years of age.
AB - To determine age-specific incidence rates of clinically diagnosed Alzheimer's disease. —Cohort, followed a mean of 4.3 years. —East Boston, Mass. —Of 2313 persons aged 65 years and older who were initially free of Alzheimer's disease, 1601 participated in the ascertainment of incident disease (80% of survivors), 409 declined participation, and 303 died before the end of the follow-up period. A stratified sample of 642 persons received detailed clinical evaluation. —Diagnosis of new probable Alzheimer's disease through structured clinical evaluation including neurologic, neuropsychological, and psychiatric examination. Community incidence rates were computed by 5-year age groups, adjusted for gender, single year of age, length of follow-up interval, and sampling design. —The estimated annual incidence of Alzheimer's disease in the population was 0.6% (95% confidence interval [Cl], 0.3% to 0.9%) for persons aged 65 to 69 years, 1.0% (95% Cl, 0.6% to 1.4%) for persons aged 70 to 74 years, 2.0% (95% Cl, 1.3% to 2.7%) for persons aged 75 to 79 years, 3.3% (95% Cl, 2.2% to 4.4%) for persons aged 80 to 84 years, and 8.4% (95% Cl, 3.7% to 13.1%) for persons aged 85 years and older. —The incidence of Alzheimer's disease is substantial and is approximately 14 times higher among persons older than 85 years compared with those between 65 and 69 years of age.
UR - http://www.scopus.com/inward/record.url?scp=0029031466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029031466&partnerID=8YFLogxK
U2 - 10.1001/jama.1995.03520410048025
DO - 10.1001/jama.1995.03520410048025
M3 - Article
C2 - 7715060
AN - SCOPUS:0029031466
VL - 273
SP - 1354
EP - 1359
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 17
ER -